NURS reports record Q2 revenue and profit, reaffirms guidance
Record Q2 revenue and profit were driven by broad-based growth, especially in direct-to-consumer and pharmacy segments. Full-year guidance was reaffirmed on expected regulatory tailwinds and strong demand.